Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 09:17 (538 d 00:20 ago) – Posting: # 20128
Views: 1,981

» » Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)
»
» What does your protocol say on exactly that matter?

My protocol says within (-0.20 and 0.20)

Complete thread:

Activity
 Admin contact
21,072 posts in 4,394 threads, 1,468 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Thursday 09:38 CEST (Europe/Vienna)

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5